Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › treprostinil

treprostinil

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of treprostinil

9 trials tracked of treprostinil: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 190 citations.

9Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 2 Phase 1 2 Other / NA 2
  1. Phase 3 Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) Completed · 190 cited
  2. Phase 4 Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication Completed · 4 cited
  3. Phase 4 Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin Completed
  4. Phase 2 A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension Completed
  5. Phase 2 Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension Completed
  6. Phase 1 A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants Completed
Show 3 more trials
  1. Phase 1 A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus Completed
  2. N/A Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH Completed
  3. N/A A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Inhaled treprostinil is the only approved therapy with randomized evidence for pulmonary hypertension associated with interstitial lung disease
Drug Pipeline Sys. Review
Inhaled treprostinil is the only approved therapy with randomized evidence for pulmonary hypertension associated with interstitial lung disease Inhaled treprostinil shows promise for specific types of lung disease
This narrative review examines pharmacological management of pulmonary hypertension associated with interstitial lung disease (PH-ILD) and i…
New research clarifies which treatments actually work for patients facing both pulmonary hypertension and scarring of the lungs.
Frontiers Aug 23, 2026
Parenteral Treprostinil Shows Efficacy in Pediatric PAH, Meta-Analysis Confirms
Pediatrics Meta-analysis
Parenteral Treprostinil Shows Efficacy in Pediatric PAH, Meta-Analysis Confirms Can parenteral treprostinil help kids with pulmonary arterial hypertension?
Meta-analysis of 143 patients shows parenteral treprostinil benefits in pediatric PAH. Data supports efficacy and safety.
Parenteral treprostinil shows clear treatment benefits and safety for children with pulmonary arterial hypertension, offering hope for famil…
Mar 28, 2026